FDA approves Gelesis prescription weight-loss drug Plenity for adults
Category: #health  By Mateen Dalal  Date: 2019-04-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

FDA approves Gelesis  prescription weight-loss drug Plenity for adults

Plenity is has been cleared for obese or overweight adults having a body mass index of at least 25

Reports confirm that the U.S. Food and Drug Administration (FDA) has recently granted approval to an innovative prescription drug aimed at helping with weight loss and weight management.

The drug has reportedly been developed by Gelesis and is called Plenity, now cleared for obese or overweight adults having a body mass index of at least 25, even if they might not suffer from other health conditions. It has to be utilized in combination with exercise and diet, besides being suitable for consumption with other weight-loss medications as well, FDA informed.

Dr. Caroline Apovian, the director of nutrition and weight management at Boston Medical Center and who was able to study Plenity in the research sponsored by Gelesis, said that this was a remarkable approval by the FDA. Apparently, most of the weight-loss treatment options are meant for patients having BMI of 30 or above, or those suffering other health issues associated with weight.

Citing reliable sources, the FDA has given approval to only five prescription weight-loss drugs apart from Plenity, in addition to continuously warning consumers against products claiming to deliver miraculous weight loss.

Weight-loss drugs approved earlier usually worked by targeting the brain for suppressing appetite or simulate the feeling of a full stomach. In contrast, Plenity is aimed at filling the stomach when consumed before a meal, sources mentioned.

Supposedly, a mixture of citric acid and cellulose in each pill expands to form a hydrogel, when hydrated within the stomach, having the consistency of chewed food. The gel, claimed to fill quarter of a stomach without adding calories, can pass through the digestive system like regular food.

According to Gelesis, people lost an average 10% of their body weight within six months using Plenity. One Gelesis-sponsored trial found that people taking Plenity exhibited twice the probability of losing 5% or 10% of their body weight across six months, in comparison to people taking a placebo.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
By Mateen Dalal

The acquisition would help Merck strengthen its presence in the renal cell carcinoma space and support its cancer drug portfolio. U.S. pharmaceutical conglomerate, Merck & Co. Inc. has recently agreed to purchase Dallas based Peloton Therapeutic...

Ikea invests in India’s one-stop interior design platform Livspace
Ikea invests in India’s one-stop interior design platform Livspace
By Mateen Dalal

The interior design platform had raised over $70 million last year with investment from TPG Growth & Goldman Sachs. The investment is Ikea’s first such deal in India, however it isn’t the company’s dalliance in India’s ...

BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
By Mateen Dalal

Sublingual administration of BXCL501 had achieved drug exposures that will be therapeutic for the acute treatment of agitation Reports confirm that BioXcel Therapeutics (BTI) has recently presented data from its Phase 1 pharmacokinetic (bioavailabil...